THC

foamboardsbeerme

i put a bunch into CAH/THC/MCK i mean just look at the stock its ready to reverse

TroubledAcorn

From what I am seeing, it looks like THC Drinks are getting a carve out at the before Nov ban. Thats just my opinion of what is happening politically. If we get certainty on THC drinks RYM will be a no brainer. I think its has potential regardless of the drinks as IP holder for GTI, but with Drinks on the table it has massive upside.

No_Firefighter9356

Are there any substances on the schedule that are found in two places? Like fentanyl is schedule 1 if you want to get high, but 3 if you are using it for surgery? I don't think so...THC by analogy is either 1 or 3 not both, no? Adult use should theoretically then be a ground ball.

skyplt29

I actually think "half empty" is being optimistic. In most cases these glasses are about 90% empty. I tdo not foresee the comeback that many seem to be hoping for. I will give Competitive Ant credit for comparing cannabis to coffee. It is a plant, albeit (I believe anyway) with far more useful benefits. There is significant potential for hemp beyond the actual CBD and THC products. I doubt we will see those heady days of 2018, or even 2021. I do remain hopeful these hearings in two weeks might provide more clarity on where this is headed. However, my journey in this sector is winding down. It is tough to look at the charts these days. BTW, I do not see too many posting rocket emojis. Those days are over.

skyplt29

The DEA has granted permission for VA researchers to import standardized marijuana extracts and THC for clinical trials, marking a significant regulatory shift in federal cannabis research policy. This authorization allows the VA to bypass current restrictions on domestic cannabis research materials, which have historically been limited to low-potency products from a single federal supplier. The move enables controlled studies using consistent, pharmaceutical-grade cannabis preparations that more closely mirror what patients actually use in legal states.

SwordfishOk504

Of course it will. Because it will be a very limited, medical-only program, potentially even limited to products like high cbd oils, not THC flower.

Hefty-Feed1400

NFA, but I was looking for something similar this past week and found IXHL, Incannex Healthcare. This is based on Gemini deep research I did: The Candidate: Incannex Healthcare (IXHL) Incannex is a clinical-stage biopharmaceutical company that recently completed a massive strategic financing round. It is currently exhibiting the textbook anatomy of a micro-cap powder keg. 1. The Deep Value Setup (Negative EV) IXHL's market capitalization is currently sitting around **$46 million**. However, following a recent institutional financing round, they reported holding approximately **$75 million in cash** with absolutely **zero debt**. This means they are trading at a deeply negative Enterprise Value. The market is effectively valuing their core clinical business, their pipeline, and their intellectual property at negative $29 million. You are buying the cash at a discount and getting the entire company for free. 2. The Cap Structure & Runway Unlike the toxic micro-caps that dilute on every 10% spike, IXHL is fully capitalized. The $75 million cash position provides an immense runway to fund their near-term development activities. Even more critically, instead of telegraphing an At-The-Market (ATM) dilution, management recently reactivated a **share buyback program**. This is the ultimate signal of confidence in a micro-cap; it tells the market they believe the stock is drastically undervalued and they have no intention of crushing the float with new supply. 3. The Catalyst A cheap valuation doesn't matter if there is no reason for volume to enter the stock. IXHL has a massive, binary catalyst on the horizon. They hold an FDA Fast Track designation for IHL-42X, a treatment for obstructive sleep apnea. They have just commenced their Phase 2 crossover dose-optimization study (the "DReAMzz" study). In the biotech world, clinical trial dosing and data readouts act exactly like INHD's AI partnership—they are the spark that ignites the low-float powder keg. To understand why the market is paying attention to IXHL, you have to look at the massive disruption potential of IHL-42X. Currently, the multi-billion-dollar Obstructive Sleep Apnea (OSA) market is dominated by CPAP machines. While effective, CPAP compliance is notoriously low because patients simply hate sleeping with a noisy, restrictive mask strapped to their face. The "holy grail" for sleep-respiratory medicine is a simple, non-invasive oral pill that can replace the machine. That is exactly what IHL-42X is designed to be, and the clinical data is backing it up. The Science Behind IHL-42X IHL-42X is an oral, fixed-dose combination of two existing, well-understood active pharmaceutical ingredients: 1. **Dronabinol (synthetic THC):** Acts on the nervous system to dampen vagal feedback, stabilize respiratory muscle patterns, and keep the upper airway dilated. 2. **Acetazolamide:** A diuretic that alters blood pH and CO2 levels, stimulating the brain's central drive to breathe. By combining them, Incannex created a synergistic effect. The drug attacks sleep apnea from two different biological angles simultaneously, allowing them to use ultra-low doses of both compounds. This maximizes the therapeutic effect while minimizing side effects. Why the Market is Watching: The Clinical Catalyst Biotech valuations move violently on data. IXHL is currently in the middle of a major transition from early proof-of-concept to late-stage validation. **1. The Proof (The RePOSA Trial)** In their completed Phase 2 trial (RePOSA), IHL-42X delivered data that exceeded market expectations. **Massive Efficacy:** The drug reduced the Apnea-Hypopnea Index (AHI)—the primary medical measurement for sleep apnea severity—by an average of over 50% in the low-dose group, with some patients seeing reductions as high as **83%**. **Clean Safety Profile:** Because it uses low doses, the drug was extremely well tolerated. Crucially, blood tests showed that the morning after taking the low-dose pill, patients' THC levels were *below* legal impaired driving limits. This removed a massive commercial hurdle. **REM Sleep Preservation:** Unlike many traditional sleep aids that ruin sleep architecture, IHL-42X did not suppress deep, restorative REM sleep. **2. The Catalyst (The DReAMzz Study)** In May 2026, Incannex officially commenced its next major trial: the **DReAMzz** crossover dose-optimization study. They have activated 14 clinical sites and fully manufactured the drug supply. This study is designed to fine-tune the exact ratio of the two ingredients before heading into a final Phase 3 pivotal trial. In biotech, trial commencements, interim enrollment updates, and final data readouts from a study like DReAMzz act as massive, binary volume triggers for a stock. **3. The FDA Fast Track Moat** Because CPAP intolerance is such a widespread medical issue, the U.S. FDA granted IHL-42X **Fast Track Designation**. This allows Incannex to communicate more frequently with the FDA and potentially accelerates the drug's path to market approval. You are looking at pre-split ghost data. It *did* have a massive, bloated share count, which is exactly why it flew under the radar of most micro-cap screeners for so long. Here is where the confusion is coming from: in late February 2026, IXHL executed a **1-for-30 reverse split** to clean up their cap structure.  Before that split, the share count was heavily diluted from its time listed on the Australian stock exchange before redomiciling to the US. But that massive float is completely gone now. The Actual Share Structure Today If you look at their current SEC filings as of June 2026, the share structure is as tight as it gets: **Total Shares Outstanding:** \~11.96 million **Tradeable Float:** \~11.8 million At a share price hovering around $3.00, an 11.8 million float is the definition of a powder keg. This is exactly why it fits the INHD setup. When you combine a tiny float of under 12 million shares with a $75 million cash pile and an impending Phase 2 clinical data readout, you have a setup where any sudden surge in retail or institutional buying volume will hit a brick wall of zero supply. That lack of supply is what forces the price to violently re-rate upward. Because Incannex officially commenced the DReAMzz Phase 2 clinical study just weeks ago on **May 14, 2026**, you are currently sitting right at the front edge of the catalyst window.  In the biotech sector, a clinical trial is rarely a single catalyst; it is a sequence of milestones that steadily de-risk the asset and draw in institutional volume. Here is the chronological sequence of triggers the market is watching for right now: Trial Commencement (Completed) Incannex officially initiated the DReAMzz study, confirming that all 14 clinical trial sites were activated and the necessary drug supply logistics were locked in. First Patient Dosed (imminent) In their prior updates, management guided that actual patient dosing would begin "in the coming months." With the trial infrastructure now live, the formal PR announcing the first patient dosed is the immediate near-term volume trigger. Enrollment Completion (late 2026) As the 14 sites cycle patients through the crossover dose-optimization protocol, the announcement that the trial is fully enrolled will signal that the data-gathering phase is locked and the countdown to results has begun. Top-Line Data Readout (tba) This is the ultimate binary event. This data will dictate the exact, optimized dosage formulation of dronabinol and acetazolamide that Incannex will take into their pivotal, FDA-cleared Phase 3 program. The market will violently re-price the stock based on these efficacy and safety numbers. The anger on Stocktwits is 100% justified. The setup I described—the tight float, the cash pile, the negative EV—is the reality for *new* money entering today. But to build that pristine balance sheet, management absolutely brutalized their legacy shareholders. If you are reading the sentiment boards, you are reading the grievances of massive bagholders. Here is exactly why retail investors are furious with the board:

Visual-Try-8081

They’re really beaten down right now. I know everyone hates Irwin because he gets paid around $1 million per month and still can’t stop the dilution. On the other hand, I think the recent BrewDog acquisition was a good move, so in my view it was worth it. Their European operations have been improving quarter after quarter, while the MSOs have almost no international market share. To add one more point (this is more of a long-term thesis), I’m confident that THC beverages will eventually be allowed in the U.S., and when that happens, Tilray will be well positioned to benefit. That said, I still dislike Irwin because of his compensation and the lack of shareholder value creation, so I only hold 1,000 shares.

LandStander420

Here’s the info we’re missing. Are you regulating pain? Trying to reduce anxiety? Looking for a better night sleep? If you’re curious and just “experimenting.” Based on the information provided, DO NOT EAT ANY PART OF THE 1k GUMMY. 5mg is your absolute max. They do sell 1.5 & 2.5 mg, that’s a much better choice. Before diving in, maybe try a low dose of CBD. Then try a low dose of CBD with 1.5 mg of THC

GeoLogic23

**Corn Rules Everything Around Me(thane)** Jim Baird is a Congressman from the midwest state of Indiana, where corn is a major crop. The US relies extremely heavily on corn for both food and fuel, which creates strains on our food supply as energy demands increase. It's not an ideal situation, so energy companies are often investigating other biofuel feedstocks that don't impact the food supply. Jim Baird was pushing for [CBD regulations to be included in the Farm Bill](https://baird.house.gov/news/documentsingle.aspx?DocumentID=266) when it was first coming up for renewal years ago. Jim Baird more recently introduced the bill to [delay the hemp ban](https://baird.house.gov/news/documentsingle.aspx?DocumentID=2520). Jim Baird's chief of staff left in 2022, and was one of the first lobbyists signed by the Cannabis Freedom Alliance. This was the cannabis advocacy group backed by **Koch Industries.** These same lobbyists worked for the **Midwest Hemp Council.** Right after Trump won, Peter Thiel's Tilray formed a lobbying group to push Republicans for cannabis reform. Their lobbyist Patrick Raffaniello was strongly connected to oil and gas lobbying, and also worked for the Advanced Biofuels Association ([Hemp Biofuel](https://advancedbiofuelsusa.info/driving-toward-a-greener-future-with-hemp-biofuels)). Prior to switching to Raffaniello, Tilray's group was using 2 lobbyists that worked for Dentons (Michael Auerbach's firm). * Alex McGee - Came to Dentons from working at Koch Industries * Andrew Shaw - Specialized in energy and environment issues, [including climate change mitigation and adaptation, renewables](https://www.dentons.com/en/about-dentons/news-events-and-awards/news/2020/february/dentons-us-elects-five-partners-in-washington-dc), nuclear power, natural gas, trade, transportation and tax. Most people have kind of forgotten about industrial hemp, but I think the infrastructure has just taken a while to build out. Especially due to COVID. If we're able to start using hemp for renewable fuels like ethanol and methane, it can alleviate pressure on corn, while being far better for the environment and also creating a giant source of natural CBD. Having a real global CBD market would make the hemp biofuel market uniquely profitable compared to other biofuels. Especially if there is also a CPG market for the lower amounts of THC that can come from that hemp. Jim Baird was questioning the agricultural secretary last week on her feelings about hemp. Clearly he has [biofuel on his mind](https://youtu.be/fSsWRFb-RwI?si=vC8AicS9fJcnq8pj&t=223). >***Jim Baird****: Do you got any thoughts on what we might be doing in regards to the hemp and where you stand? There's a November 12th deadline coming up. Got any thoughts on what we might need to do, or where we're headed next. I'm talking about industrial hemp, with the fiber production.* ***Because that has to do with turning it into methane and that sort of thing****.*

FacebangsTucans

Sold my $350 puts yesterday would’ve been 4600 today, wasn’t able to enter a trade because of settlement I tracked would made 1250 . Just a young guy trying to make a small amount of capital.. feeling depress today stop loss popped lost 200 Last 400 riding on next Friday calls. Might seem little to you guys but I make $26 hour don’t have much to my name but I’ve pulled off some incredible trades before (5200% gain on NTFL worst earning ever) flipped 500 with 3 day trades into 4k etc.. I like to think I have what it takes to do well trading. Been working on discipline, stop losses, leveraging, taking profits.. Idk feeling depresso this Friday night got a couple beers got my THC drink trying to relax play some games but I ask myself maybe I was never really a good trader Work as a broker so I’m Around this industry 24/7 but maybe I just stay on the sidelines.. VOO chill.. idk feeling off

Own-Buffalo1445

Or maybe some THC therapy 🙂

Kutukuprek

RYM is already listed on the NASDAQ, so GTBIF could engineer a medical/recreational split instead of THC/CBD here and access the public markets the quickest of the big 3. The CBD opportunity will be a headache to manage though. But ultimately it looks like public market access for medical could be worth many multiples of the CBD opportunity, so they can handle that later somehow. Or just lump it together with the medical business. In any case I have faith that the GTBIF peeps will think this through.

mcorliss3456

Now about that illegal hemp-derived THC, Governor…

PrimalBotanical

The current ban language includes any product containing more than 0.4mg of THC per container, so all full spectrum CBD products will be illegal in November.

Eliav_1991

the wellness framing is mostly irrelevant to the ban exposure. the real question is what "intoxicating hemp" gets defined as in the final rule. charlotte's web is almost entirely CBD-based, not delta-8 or delta-9 derived, so the current ban language doesn't obviously touch them. the risk is a broad definition that sweeps in full-spectrum extracts, even low-THC ones. been watching their filing disclosures on wiseek and the consistent language is FDA regulatory uncertainty being the bigger overhang, not the intoxicating hemp ban specifically. if FDA punts on CBD rulemaking again, that ambiguity is the actual drag on the business.

perceptive_AI

Edibles made me lazy and not trade. Stopped it and my portfolio is growing. I guess THC is my kryptonite.

PrimalBotanical

The ban criminalizes any product containing more than 0.4mg of THC per container. Most of Charlotte’s Web products contain more than that, so they will be illegal in November.

EducatorReady1326

Yes if it’s used medically a business would likely register. charlottes web is a cultivar so yeah it’s obviously full spectrum but a quick google search indicates it’s contain less then 0.3% THC so it’s still hemp and not going to be banned.

GeoLogic23

I actually do think that oil has a role to play in our market, surrounding extracted CBD/THC products. Industrial hemp supply chain is coming only slowly, but within that are large biofuel projects like SGP in Panama. They are partnered with Honeywell and have billions in funding. Industrial hemp being allowed in our biofuel supply chain would set a pricing floor for hemp, while also giving them access to a market with essentially infinite demand. If agricultural waste from hemp could be sold as biofuel feedstock (even for very low prices) that would be a crazy good margin booster for low dose hemp products. By the time you're extracting CBD/THC you might already have been able to turn a profit on the industrial parts of the plant. This was Bruce Linton's next move once he left Canopy Growth. He was going to be investing in the hemp supply chain along with other ex-Canopy people. Biofuel feedstock that **doesn't impact the food supply like corn**, doesn't use a ton of water, and can be grown in a variety of environments is actually an extremely valuable resource. The biofuel market is gigantic, and only going to continue to grow. It's much more important to the world than any CBD/THC market will ever be.

King_Chron

The fundamental conflict between marketing claims and biological reality forces a sharp divergence in how criminal courts and private corporations view cannabis breath technology. While companies like Cannabix Technologies pitch their devices as a definitive solution for recent use detection, federal and independent research has repeatedly verified that chronic users can harbor baseline THC concentrations in their breath that mimic active, recent intoxication. This lack of data separation creates entirely different sets of legal and functional realities for judges and corporate executives. In criminal law, a positive breath test from a device measuring a single snapshot of Delta9THC is currently scientifically indefensible due to a lack of baseline distinction and clear impairment metrics. Becausen Delta9THC is highly lipophilic (fat-soluble), daily or medical cannabis users continuously slowly bleed stored THC from fatty tissues back into their circulatory system and lung lining. A pilot study published in the [*Journal of Breath Research*](https://pmc.ncbi.nlm.nih.gov/articles/PMC10201171/) demonstrated that daily cannabis users frequently have active THC present in their breath aerosols despite verified abstinence of 12 to 24 hours. Furthermore, a joint study by the [National Institute of Standards and Technology (NIST)](https://www.nist.gov/news-events/news/2023/05/researchers-analyze-thc-breath-cannabis-smokers) and the University of Colorado Boulder confirmed that the quantitative amount of THC found in a regular user's breath *prior* to consuming cannabis on any given day can be virtually identical to the amount found in their breath *an hour after* active consumption. This led federal researchers to conclude in an official report summarized by [*Marijuana Moment*](https://www.marijuanamoment.net/federal-researchers-claim-first-ever-detection-of-cannabinoids-in-human-breath-after-use-of-marijuana-edibles/) that data does "not support the idea that detecting THC in breath as a single measurement could reliably indicate recent cannabis use." Additionally, unlike alcohol's linear relationship with Blood Alcohol Concentration (BAC), there is zero scientific consensus linking a specific picogram level of breath THC to motor or cognitive impairment, with a comprehensive review in [*Scientific Reports (Nature)*](https://www.nature.com/articles/s41598-021-02137-x) highlighting that no meaningful correlation has been established between impairment and Delta9THC levels in any tested matrix to date. Consequently, a defense attorney can easily introduce reasonable doubt by demonstrating that a positive breath test from a daily user reflects a sober, resting baseline rather than active, recent intoxication at the wheel. Conversely, for private employers managing safety-sensitive jobs like construction, manufacturing, and transport, the technical flaws that ruin a courtroom case are treated as an acceptable risk margin. Employers primarily look to filter out the weekend or occasional consumer, knowing that if an occasional user smokes on a Friday night, their breath clears completely by Saturday morning; a positive test on Monday morning thus provides a reasonable deduction of weekday impairment. While companies accept that this technology unfairly catches chronic or medical users who are not actively impaired, corporate risk management views a "false positive" on a sober but frequent user as a safe compliance buffer. Unlike criminal prosecutors who must prove impairment "beyond a reasonable doubt," employers rely on at-will employment and collective bargaining agreements to enforce internal policies. As outlined in [Cannabix Technologies' own regulatory disclosures](https://cannabixtechnologies.com/site/assets/files/6587/2024_md_a_cannabix_-_final.pdf), companies utilize these tests simply to establish compliance with arbitrary "zero-tolerance" or "clear-headed duty" workplace rules, granting administrative justification to terminate or suspend an employee and shielding the business from workplace liability insurance spikes.

EducatorReady1326

The rescheduling should have a positive impact. I don’t know the THC % but if it’s legally hemp the ban shouldn’t impact it. It’s really not a hemp ban it’s eliminating the THCA loophole and people selling plants/seeds that are not mature enough to produce THC but will when flowered. Sounds like enforcing it will be tough.

ThetaFarmingRegard

quit Zyn, alcohol, THC and cocaine 48 hrs ago im doing ok, thanks for asking

GrandKnew

I am sitting in my basement apartment vaping THC distallate listening to the tweakers walk by outside (whom I will soon be joining if this shit keeps up)

wentzco

I admit this wasn't on my "next" list for Vireo Growth to acquire. You can see Bridgewell Agribusiness's site at [https://www.bridgewellab.com/](https://www.bridgewellab.com/) to see what they all do. Just some ideas where this "may" be the reasons why Vireo Growth acquired them. \- This likely is only a "very small reason" but Bridgewell's PAR4® protein meals, mineral products and natural fertilizers can be added to Hawthorne Gardening Company. This also may lower cultivation costs. It may be a larger reason than I think however. \- Bridgewell has the ag/food connections for sourcing, supply chain, logistic/distribution, manufacturing, warehousing (their own warehouse as well) & vendor relations. Bridgewell's food safety certifications also are vital. This may be a signal that Vireo Growth is developing a product line(s) to be sold in dispensaries. That's not all. There are other non-THC (or low) hemp/cannaboid/extraction products that may be created into food products to massively expand opportunities far outside of dispensary-only distribution. \- This acquisition does diversify Vireo growth's revenue stream but also enhances the main cannabis business. Vireo Growth's cannabis biz strategy is heading the route to have a full ecosystem of cultivation, wholesale, retail, logistics, tech & agricultural infrastructure... an Amazon-like force in the arena IMO. It will be really interesting to start getting more details/reasons/plans directly from Vireo Growth for this acquisition.

deadly_poison7

I've never invested, and I'm always in the red. I'm on WSB to get really pissed off. To make money, you need money. How the fuck am I supposed to change my life? My dream is to escape Italy and go somewhere where I can work with THC and live in peace (but sales licenses cost over 200,000). Unrealistic.

ThetaFarmingRegard

THC

snark42

>At best it will be products like oils, or like Epidiolex (already approved). I could see a THC extract/tincture as an alternative to Marinol or Syndros too.

AverageNo130

Charlottes Web has some new THC edible gummies and high quality CBD product.

CallShot7029

80% of people whose it do not qualify for the specific conditions it’s meant to treat. They buy compounded OTC stuff. It is essentially where the weed market is headed. Most will buy rec or with their med card, a thin subset (though increasing with each FDA approval will get a THC derivative prescribed and paid by insurance

Ok_Needleworker2520

What are the actual THC limits ? It doesn’t say in the article

TroubledAcorn

No, not personally. I believe the Drinks are here to stay and it will be worked out before the ban. Even if the ban does stick, individual states are making their own rules and regulations on THC Beverages. Just like how Cannabis was federally illegal yet we have states that create their own laws on it. This is all short term stuff. The Drinks are popular and here to stay, they are not going away. If we zoom out 5-10 years THC Drinks will be widespread and socially acceptable alternative to alcohol sold in most places

CaptAmericaCaveman

Any concerns for RYM and incoming hemp derived ban November 2026? Will hinder RYM THC drinks in non-dispensaries growth, distribution channels like Circle K and package/liquor stores??

CaptAmericaCaveman

Any concerns for RYM and incoming hemp derived ban November 2026? Will hinder RYM THC drinks in non-dispensaries growth, distribution channels like Circle K and package/liquor stores??

CaptAmericaCaveman

Any concerns for RYM and incoming hemp derived ban November 2026? Will hinder RYM THC drinks in non-dispensaries growth, distribution channels like Circle K and package/liquor stores??

HerezahTip

Inshallah brother. THC and caffeine for breakfast, let’s trade

TheTigerKingMan

Look man, the "ineptitude" argument is a fairy tale. If you think the government and the big players are just bad at this you aren't following the money. This wasn't a mistake it was a setup imo. Let me elaborate fr  1. The Schedule 3 Trap You’re hype about rescheduling? Look at the fine print from last month (April 2026). Moving it to Schedule 3 is a gift to Big Pharma, period. It lets them start clinical trials while the local dispensaries stay stuck in a legal gray area. It’s the "Oxy" playbook all over again. They don't want "legal weed"; they want "prescription weed" that they can charge $300 a bottle for. 2. The Stock Slaughter Stop calling it a "bad investment." It was a liquidation. Look at the tickers: CGC (Canopy) is down like 98% from its high. MSOS is sitting under $5. ACB is basically worth zero. That’s not a market correction. That’s the big boys pumping the hype, taking retail investors' money to build the warehouses, and then crashing the price so they can buy the infrastructure back for pennies during the bankruptcy hearings. 3. The Corporate Crack Factor We went from 5% THC reggie to 95% THC concentrates in a decade. You think that's for the "culture"? No, that’s for the dependency. They engineered the plant to be as addictive as possible to ensure "customer lifetime value." They literally legalized a version of the plant that causes psychosis just so the tax revenue stays consistent. You're waiting for "incrementalism" to save the day? The big players love incrementalism because it gives them time to lobby for rules that kill the "mom and pop" shops. By the time it’s "fully legal," there won't be any independent shops left. It’ll just be a Choice of Pfizer Weed or Bayer Weed. It isn't a conspiracy, it’s just the American business model. The rich got the IPO money, the poor got the addiction, and the retail investors got the bags. End of story.

TheTigerKingMan

I’m 40. I’ve seen the transition from street reggie to "corporate crack." If you’ve been paying attention to the industry, you know something is off. This wasn't just a "bad investment" for the public it feels like a 10-step plan to consolidate power and money while leaving the public addicted to a high-potency version of a plant we used to just giggle on. **1. The Stock Investor "Squeeze"** The promise was simple: Buy in early before federal legalization, and you’ll be a millionaire. Instead, almost every major cannabis stock (CGC, TLRY, ACB) has crashed 70–90% since their IPOs. While retail investors lost their shirts, the big players and institutional "smart money" used the volatility to reposition. The Global Cannabis Stock Index has dropped over 93% since its 2021 high. The "boom" was a joke intended to drain retail capital. reference \\/ [https://www.newcannabisventures.com/cannabis-stocks-rally-begin-2026-badly/](https://www.newcannabisventures.com/cannabis-stocks-rally-begin-2026-badly/) **2. Engineered Addiction via Potency** The government allowed businesses to sell products that are 10–90x stronger than what we had in the street weed days. We went from 4% THC in 1995 to flower hitting 35% and concentrates hitting nearly 100%. This isn’t "natural" anymore. These high-potency products are scientifically linked to increased risks of psychosis, schizophrenia, and Cannabis Use Disorder (CUD). They basically legalized a version of the plant designed to maximize dependency. reference \\/ [https://drugpolicy.org/wp-content/uploads/2026/03/2026.03\_High-Potency-THC-Report-FINAL.pdf](https://drugpolicy.org/wp-content/uploads/2026/03/2026.03_High-Potency-THC-Report-FINAL.pdf) **3. The "Schedule 3" Trojan Horse** The DOJ finally reclassified cannabis from Schedule 1 to Schedule 3 in April 2026, but look at the fine print: it primarily benefits **medical** businesses and Big Pharma. It allows them to deduct business expenses under 280E, but recreational shops are still largely stuck in a legal gray area. This feels like a setup to let independent dispos go bankrupt so Big Pharma and Big Weed can buy the remains for pennies on the dollar. Big Pharma controls weed, jacks the price to the ceiling, and you'll be left paying out of pocket costs because the federal government hasn't approved of marijuana only the state. [https://www.eisneramper.com/insights/tax/executive-order-rescheduling-of-cannabis-0226/](https://www.eisneramper.com/insights/tax/executive-order-rescheduling-of-cannabis-0226/) **4. The "Dead Internet" and Reddit Control** You can't even get a real conversation going about this without being drowned out by bots or "slop" engagement. Look into the **Dead Internet Theory** the idea that most of what we see is bot-driven to shape public perception. Reddit is now a publicly traded company (RDDT). It’s in their financial interest to curate what you see to favor their biggest stakeholders. You’re being sold a "legalization dream" by algorithms while the reality is a wealth transfer. [https://en.wikipedia.org/wiki/Dead\_Internet\_theory](https://en.wikipedia.org/wiki/Dead_Internet_theory) **The Bigger Scheme:** The rich got richer off the IPOs, the poor got poorer investing in the "hype," and now we have a population hooked on concentrates that cause mental health issues. If they take away the dispos next, they’ll leave a bunch of addicted Americans running back to the streets or Big Pharma for "treatment" for the very problems the legal market created. Correct when I'm wrong, but didn't the Government/Doctors/Big Pharma do this with Oxy/Pain Killers/Alcohol? **TL;DR:** The government didn't legalize weed for you; they legalized it for the taxes and the corporations. They let it get 100x stronger to ensure people stayed hooked, and now they're letting the stocks and independent shops fail to let the real "owners" take over.

GeoLogic23

RYM with another partnership. Official THC beverage partner of [Opry Entertaiment Group Venues](https://www.globenewswire.com/news-release/2026/05/14/3294752/0/en/se%C3%B1orita-named-official-thc-beverage-partner-of-opry-entertainment-group-venues.html). >As the official THC beverage partner, the delicious agave-based cocktails will be available at the Grand Ole Opry, Category 10 Nashville, and Ascend Federal Credit Union Amphitheater in Nashville, Tennessee; ACL Live at The Moody Theater in Austin, Texas; and Ole Red locations in Nashville, Tennessee, Orlando, Florida and Tishomingo, Oklahoma. This is the comment that I really noticed though. >Señorita has also expanded to Chicago's 16" on Center venues, including The Salt Shed, and **Georgia-based Oak View Group venues**. Oak View Group is a major player in arena and theater management, and are partnered with Live Nation. They have been pursuing hemp beverages for years, and are partnered with Green Monke and Cookies. RYM already partnered with the United Center, which was a founding member of Oak View Group's Stadium Alliance. If they are further connected to Oak View Group, you can expect future large arena/theater deals are coming.

YTLupo

Yes but most of it is in THC Form.

1_FCKTRD

On November 12, 2025, Congress signed into law legislation instructing the FDA to develop a list of approved and classified cannabinoids. The Continuing Appropriations Bill (H.R. 5371) set a 90-day deadline for the FDA to publish a list of all known cannabinoids, including naturally occurring compounds, THC-class compounds, and compounds with "similar effects". On May 12, 2026, Dr. Marty Makary was replaced as FDA Commissioner, with Kyle Deontes stepping in as Acting Commissioner. Either get on board or step aside.

GeoLogic23

Definitely a bad quarter, but they've had bad Q's in the past and adjusted and done fine afterwards. Like when the high THC stuff was getting dumped on the market. Even with such a bad quarter, they're not actually losing that much money, especially compared to what BAT has invested recently. So the sky isn't falling. BAT will find a way to give them a little more money if they really need it, but just turn it around slightly next Q and they'll be totally fine. Just always be taking some profits on pumps, so you can be ready for any situations like this. Not much else to say about Canada rec, other than hopefully they adjust like they did in the past. Nobody is making tons of money there, even the profitable companies. If OGI could make tons of money in Canada rec that would be great. But tiny Canada is just a staging ground for international medical and hemp and stuff. Still waiting on that EU-GMP certification at their one facility I see. I don't think turning their Canadian recreational into a cash cow is really the end goal. More like R&D and product development that hopefully doesn't lose too much money. BAT is looking towards the US, EU, and eventually places like India, where BAT has a significant presence. Even if they completely dominated Canada it still wouldn't be that big of a win for BAT, with their market cap >$100B. BAT only cares about the big markets in the long term. It's funny that some people seem to think OGI is in some serious trouble as a company, like on the path to go out of business or something, when BAT is has been making all these moves for them. Not like BAT thought they were going to buy Sanity and then just coast on profits the rest of the way, regardless if this one Q was good or bad. BAT has been invested in Sanity since 2022. Way before they had OGI follow up on their investment. They knew they were running OGI's cash super low with that move, but they also knew exactly what they were investing into. So we'll see. More moves are certainly on the way. I have no reason to think BAT is just planning on OGI to organically grow from where they are at this moment. Now one specific thing I thought was interesting is that OGI seems to have written down about $6M in hemp investments in the US. >In addition, the current period results were negatively impacted by a $5.8 million impairment loss related to the Company's hemp-derived products business in the U.S. But BAT was also separately investing more into Charlotte's Web recently, who pretty much only do hemp in the US? Maybe it was just a NASDAQ thing where OGI had to write it down before the ban actually happened? Idk. Just thought that was an odd thing between the two BAT companies.

Forest_City_Frolfer

Q2 FISCAL 2026 HIGHLIGHTS Gross Revenue: $93.3 million (-9% year-over-year). Net Revenue: $59.8 million (-9% year-over-year). International Revenue: $6.1 million (0% year-over-year). Adjusted EBITDA2: $0.9 million (-82% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2 in flower, #2 in pre-rolls, #3 in edibles, and #5 in beverages1. Sanity Group GmbH (“Sanity Group”) Acquisition: Subsequent to quarter-end, Organigram completed its acquisition of one of Germany's cannabis leaders, Sanity Group. Sanity Group is expected to generate approximately €25 million in average quarterly revenue over the next calendar year, and provide a scalable platform to accelerate Organigram's growth across key European markets. Australia Branded Sales: Launched 10 vape and gummy SKUs in Australia under the BOXHOT and Edison brands, with products expected to be available to over 4,000 pharmacies. Record Yield and Potency: Achieved a record quarterly harvest of over 32,000 kg (+56% year-over-year) and the highest average THC potency across the Company's flagship Moncton facility compared to any prior quarter due to continued enhancements to cultivation practices. Plant Science: Advancing Organigram's recent achievements in early-stage genetic marker identification, the Company launched two powdery mildew resistant cultivars and continues progress toward the identification of other genetic traits including, but not limited to aroma, color, terpene expression, and disease resistance. My Notes: Revenue down 9% Y/Y Adjusted Gross Margins down to 31% from 33% Negative Net income, Cash Flow, and Adjusted EBITDA They are struggling. With such low margins it will be challenging to grow marketshare, they cannot compete on price anymore. International medical is flat. They used up a lot of their remaining cash acquiring Sanity Group. Overall, I am surprised, I expected slow improvement, but this quarter looks like they have regressed across the board.

Confident-Income

It is bad news as it means Cresco will not get an initial license to build out operations in TX. Not that it affects the company's current financials but it'll be one growth opportunity they will miss out on. Someone with more knowledge than me about TX's regulatory environment can chime in but from what I understand, operators first have to open retail shops in all the public health regions before being allowed to build more stores in each region. So the quicker an operator can open new stores in all the regions, the quicker they can target the high population cities.  Not sure how big the TX market will become with just low limit THC allowed so the potential may not be all that big yet. But if the program expands in the future, it's better to have a presence already established. 

No_Fig_7835

If only THC didn’t fuck with rem sleep. I love getting high at the end of the day but then I don’t get my beauty sleep

No_Love_Gained

Just the sheer amount of lobbying dollars spent the last few quarters will ensure hemp-derived THC products will end staying around irrespective of the ban..jmho

HigherGroundHoonigan

I know A LOT of people who are struggling immensely in this economy. One of the first things they stopped doing was maintaining their medical card and even buying medical marijuana in general. Majority of the users I know are young millennials or older who are working professionals and use it for anxiety, sleep issues, or pain and it's something they can "do without" due to rising costs of everything. ' My guess is that their declining revenue is largely attributable to that. The other part would be the CBD/THC drinks. And honestly, I get it. I have my medical card but 9 times out of 10, I pop open a Keef /Onward or put some Nowadays in a soda. AU would is their golden ticket if we can ever get there.

GeoLogic23

[Navy Pier Names RYTHM as Its Official THC Beverage Partner](https://www.globenewswire.com/news-release/2026/05/08/3291219/0/en/navy-pier-names-rythm-as-its-official-thc-beverage-partner.html) >New multi-year partnership brings Chicago’s leading THC brand to the Midwest’s most visited attraction. >RYTHM, Inc. today announced that Navy Pier has named RYTHM, Chicago’s flagship THC brand, as its official THC beverage partner, bringing hemp-derived THC beverages to the most visited destination in the Midwest, **welcoming more than 8 million guests annually**. The multi-year partnership launches May 22 and centers on the RYTHM Stage in the Navy Pier Beer Garden, brought to life through events, pop-ups, sampling, and seasonal programming. >Guests will have access to RYTHM’s full beverage lineup, including Sativa and Kush, each designed around distinct, effect-driven experiences. Señorita THC Margaritas will also be available alongside RYTHM **at the garden and at select bars and points of sale across the Pier.**

TroubledAcorn

$RYM a company with a guaranteed 70m annual income in royalties and the most funding and first mover advantage in THC Beverage space. The future is bright.

manualCAD

I saw some of Curaleaf's marketing for their Anthem sativa heavy "pre rolls" (they look like cigarettes). Is there a market for this type of product? I see the idea and vision, just wasn't sure if the market is even there for low THC, sativa dominant 0.5-0.75g cigarette-like pre rolls.

GeoLogic23

Btw sorry, I'm not really trying to convince you or anything. It's totally reasonable to not think the THC beverage market is a thing. I believe there's lots of evidence to the contrary over the last few years though. Just a good place to get some thoughts out. Your first point of how to differentiate. That's all about distribution. **Everything about the beverage market is about distribution**. My first link says how at that point they were estimating only 30 or so brands had real distribution. Take a super popular beverage brand like Celsius. It was around for a long time before getting plugged into Pepsi's network and becoming one of the top energy drinks. And I think it tastes just ok. Then about the person drinking a THC drink vs hitting a 90% vape. You're still thinking they are the same consumer. They are not. The whole point of beverages taking off **specifically when they began to be sold in regular retail** is that the people buying low dose beverages are not the same people who even use high dose products at all. These are people who really do not even set foot inside of dispensaries. Listen to every single hemp beverage company and they will say this same thing. One of the fastest growing categories is "wine moms" who are replacing one glass of wine with a THC beverage. I have personally brought THC beverages to multiple events where normally there would maybe be a small amount of alcohol consumption, but not much. Multiple people who wouldn't have drank alcohol chose to drink THC drinks, without me prompting them to try them. These people would not be ripping a vape at this social gathering, but they would casually drink a THC drink. Also the 90% vape argument is the exact same you could make for beer. Why drink a beer when I could rip a shot? Why drink a light seltzer when I could have a flask of Everclear? Then this point: >Maybe way in the future we get them sold at bars or sporting events This is already happening. Several of the links I gave you were bars. There are also going to be lots of partnerships like RYM made with the United Center. Even smaller partnerships can be massive depending on the size of the company. There are so many deals to go around. A major arena management company called [Oak View Group has been preparing to launch hemp beverages at their venues for a couple years now](https://www.globenewswire.com/news-release/2023/10/19/2763417/0/en/St-Peter-s-Drinks-and-Oak-View-Group-Partner-to-Introduce-Green-Monk%C3%A9-Hemp-Derived-Drinks-at-Live-Entertainment-Venues-Throughout-U-S-and-UK.html). They have partnerships with Green Monke and Cookies. The United Center (RYM partnership) was a founding member of Oak View Group's Arena Alliance. Oak View is also partnered with Live Nation for hosting Arena events. This isn't some small mom and pop company. They are already [launching THC beverages in their theater venues](https://urbanmilwaukee.com/pressrelease/green-monke-becomes-exclusive-hemp-infused-beverage-of-pabst-theater-group-a-milwaukee-entertainment-institution/) such as with Pabst Theater Group. Note that the brewing company Pabst has also long been eyeing the drinks market. They have had "[Pabst Labs](https://www.pabstlabs.com/)" for years. Lastly, regarding trying to guess who is going to be Budweiser. I don't think I need to guess who is going to be Budweiser. I care who will increase their market cap by a reasonable percentage from where it is now. Whether that is Jones Soda turning into a $200M company, RYM turning into a $2B company, Tilray turning into a $5B company, or AB InBev turning into a $500B company. It just matters that you pick someone who will grow from where they currently are. As mentioned above, Green Monke is now the official THC drink at [Pabst Theater Group](https://www.pabsttheatergroup.com/connect/our-partners). This is alongside Molson Coors, Jack Daniels, Casamigos, and Sun Cruiser. No Budweiser in sight. There are plenty of these smaller partnerships to go around for many brands to find success. Thinking you need to pick the Budweiser in order to win is the same fallacy as only caring about which cannabis company has the most revenue. The biggest company isn't always the best investment.

GeoLogic23

Yes I definitely do think the THC beverage market will continue to expand rapidly. I really think people just keep looking at cannabis beverage sales from regulated dispensaries over the years, and not seeing the change in retail that happened in Minnesota (then spreading across the US). Once beverages began being sold in regular retail, they actually started capturing significant percentages of sales in just a couple years. [From late 2025](https://www.cbsnews.com/news/cannabis-infused-drinks-target-thc-beverages/) >Whitney Economics estimates there are 500 to 750 brands marketing cannabis drinks. Of those, **roughly 30 are sizable labels with national distribution**, while the rest are regional and local brands, according to Diana Eberlein, chair of the Coalition for Adult Beverage Alternatives Retailers That was from the chair of the hemp beverage advocacy group Tilray helped start recently. This is key to seeing who can actually compete in a developed market. People selling small quantities direct to consumer have no way to scale to large, consistent production and selling through the three tier system. You need to consistently get your properly dosed product to your retailers, or they aren't going to work with you. But about sales quantities. [Indeed Brewing in Minnesota](https://www.thedrinksbusiness.com/2026/02/craft-brewers-turn-to-thc-drinks-for-growth-as-legal-uncertainty-looms/): >“THC is not our entire business, but it has become an increasingly important component of it,” says Ryan Bandy, chief business officer at Indeed Brewing Company in Minneapolis. “I’d say it is responsible for about **15% to 20% of our volume and delivers 25% to 35% of our revenue**. We’ve also hired more people because our business has grown. I’d say we’ve boosted our staff by about 15% simply because of the increase in volume. Without the THC line, we wouldn’t be going out of business, but we wouldn’t be nearly as healthy.” Note that this is highlighting why I think THC beverages are important. You can sell lower volume for higher revenue and profit. Distribution savings could be massive in themselves. [Jukebox in Ohio](https://www.wkyc.com/article/news/local/ohio/ohio-bars-breweries-impact-state-law-bans-sale-thc-seltzers-hemp-weed-drink-money-alcohol/95-099e4445-d966-4232-af29-c603ccff34b2) >At Jukebox in Ohio City, **THC seltzers make up nearly 10% of all sales**. Owner Alex Budin says the business has no choice but to comply, despite the expected hit. >"We're going to pull it. We don't really have any other recourse. It's going to hurt our bottom line; we hope that customers will adjust," Budin said. "I know I won't close because of this, but it's going to hurt." [Funky Buddha in Florida](https://www.sun-sentinel.com/2026/04/23/buzzkill-thc-drinks-are-exploding-at-south-florida-bars-breweries-and-restaurants-but-will-they-last/): >hemp drinks with trace amounts of tetrahydrocannabinol (or THC), are surging. Which is why using Funky Buddha’s 115,000-square-foot warehouse for **co-packing hemp-derived THC drinks is a lucrative side hustle** THC drinks are cheaper and faster to make than traditional alcohol. The more you switch to faster THC products, the more room you give yourself to co-pack for others. [Top 10 Liquors in Minnesota from 2023](https://www.marketwatchmag.com/cannabis-drinks-mean-big-business-for-liquor-stores-in-minnesota/): >Since it became legal for Minnesota liquor stores to sell THC beverages on June 1, sales have been raging. “**We are approaching 10% of our sales being THC drinks,**” says Jon Halper, owner of Top 10 Liquors >“When we first launched the category, **the supply chain was a little slow because we went from zero to 100mph overnigh**t,” he says. “Now the supply chain is really solid.” I've discussed what happened with THC beverage supply chain in the past. In 2019 Canopy discovered can liners were making cannabinoids stick to them. That got fixed but then COVID hit and disrupted everything. Pretty soon after COVID went away the hemp beverage market blasted off in Minnesota because they started being sold in regular retail. People keep citing how they aren't selling in Canada, but even in Canada they aren't sold in regular retail yet. People point back to like 2021 and say there was 0 growth in beverages for years. Right, and that's because the real THC beverage market didn't even start until halfway through 2022. Since then it's been nothing but rapid expansion and adoption. [Florida Liquor Store in 2025](https://ecrm.marketgate.com/Blog/2025/09/THC-Beverage-Consumers-Are-a-Surprisingly-Diverse-Group-at-This-Florida-Restaurant-Chain): >Despite challenges, the opportunity for growth is undeniable. In just **six months, THC beverages have shot to 3 percent of sales** at the Clearwater Beach liquor store. “That may not sound huge, but **going from zero to 3 percent that quickly is a big deal**,” Sousa says. “And we’re just getting started.” Target, Circle K, Total Wine, and all kinds of other alcohol sellers are getting in on the market based off organic growth from random scattershot brands. Just think what could happen once actual alcohol companies start pushing specific brands.

heliumbox

My bad, not TLRY specifically taking the "beverage" market by storm but even being a player in thinking the beverage market itself will take off. I am personally extremely skeptical of the beverage market potential and again see it as a *far* off market when looking at the pace legislation is moving. I just do not see THC beverages being even 10-20% of sales for any alcohol producers after 10 years once it is even legal. I do not see it becoming legal, at scale, across state boundaries, and completely rewriting current state by state laws or federally permissible in any near future.

Cool_Ad_5101

Disagree some people benefit from pure CBD for sleep, others ‘need a combination of THC and CBD. The same can be said with pain management. So I wouldn’t speak in absolutes. You can cite your experience as I can cite mine being in the healthcare space fo 13+ years and in the pain management space for half of those 

SwordfishOk504

If that was the case, 99% of hemp growers wouldn't be growing for flower to convert to THC

GeoLogic23

[America First Agriculture](https://www.reddit.com/r/weedstocks/comments/1rznklq/comment/obnfi97/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) is a hemp group lobbying with a firm very close to Trump. >By modernizing policy, AFA envisions Cannabis as a sustainable feedstock that can **compliment petroleum in industrial applications, from bioplastics to renewable energy** [Honeywell](https://www.reddit.com/r/weedstocks/comments/1o6bfgl/comment/njgx7ai/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) is also working with a project in Panama on [hemp technology](https://www.honeywell.com/us/en/press/2024/10/honeywell-and-sgp-bioenergy-to-develop-plant-based-biochemicals-reducing-industry-reliance-on-fossil-fuels). >Honeywell and SGP BioEnergy today announced they are working together to develop new, scalable technology to **convert industrial hemp** and other plant-based material into biochemicals that can be used to **produce plastics and other everyday items, offering an alternative to chemicals produced from fossil fuels.** >As part of this collaboration, Honeywell will develop the new technology that enables plant material to be used as feedstock for biochemical production on an expanded scale. SGP BioEnergy will provide the infrastructure, workforce and second-generation feedstock, including industrial hemp, for this initiative through its “READY.GROW.” program. >To ensure safe and efficient unit operations, Honeywell will provide ongoing operational support and workforce training for the team at SGP BioEnergy. The collaboration with SGP BioEnergy supports Honeywell’s alignment of its portfolio to three powerful megatrends, including the energy transition. >“Honeywell is committed to developing innovative solutions to help enable the energy transition. This cutting-edge technology will enable the production of a variety of petrochemical alternatives using second-generation feedstocks,” said Bryan Glover, chief technology and growth officer of Honeywell Energy and Sustainability Solutions. “**By using hemp and other non-edible feedstocks to produce these important chemicals, Honeywell and SGP BioEnergy are helping to reduce the world’s reliance on fossil fuels without impacting the food chain.**” This is what I'm saying is the key to a massively profitable CBD/THC market. We really need to take some reliance off food chain products (like corn) in the production of biofuel by using hemp (way better than corn). Especially as we scale up our biofuel target goals.

Local_Many_9108

tell that to the 90% THC carts ive been smoking every day the last 4 years

NewLifeInAfghanistan

15 mg of THC hits me like a truck. Feel like I'm one of those kids from Love on the Spectrum right now

GeoLogic23

I grew up poor, in a rural part of one of the most conservative states in the country. That forced me to do a lot of independent learning my whole life, because our schools were so bad and I definitely wanted to live somewhere else. I managed to get chosen for a very good scholarship in 8th grade for poor kids who showed lots of promise. I will brag a bit and say that only 51 kids in the whole country got it that year. It paid for lots of summer programs all through high school, and later paid for all of my college. Instead of leaving my friends for a private high school, we worked out a deal where I just took extra study hall periods throughout high school where I would prep myself for college. So I've been researching stuff by myself my entire life. Whether it be calculus or cannabis. I went to a very good engineering university, and then went from my ultra-GOP ultra-rural hometown to living in one of the largest and most liberal cities in the country. I never actually cared that much about advancing my career though. I just stayed with the same very small company since college, and these days I just make my own hours and do more like consulting type work for them. They're good people, so I'm happy there, even if the money is not great at all. A decent bit of my career has been reading and actually understanding government regulations and product safety standards. Mostly stuff written for the construction industry though. I'm a civil/environmental engineer, so I have lots of interest in all the other applications of hemp. You should see how much of our work has shifted in recent years towards products that contribute to decarbonizing the concrete industry. This includes getting requests recently to test hempcrete products. We should really be using hemp for biofuel, instead of propping up the corn industry. So many ways hemp can be used for decarbonization, and if that potential is seriously monetized in any way (especially if it gets government subsidies) then there's just a gigantic supply of free CBD/THC sitting out there. It's a gold mine, and big tobacco and big alcohol know it. But anyways, I decided to get into stocks to make extra money, since I never particularly felt like corporate grinding at a different company. I also have seizures that I have treated for many years with cannabis, because the epilepsy drugs they tried to put me on gave me really bad side effects. That's why I was already extremely familiar with medical cannabis and the origins of Charlotte's Web, as they were really the pioneers of treating seizures with cannabis. So I'd actually dabbled with investing in the cannabis industry in small ways since like 2014, but I got into it seriously when Constellation made their first investment in Canopy. And then part of why I spend so much time researching the cannabis industry is because I'm stuck at home the vast majority of days taking care of my mom. She's been having serious issues for years, and has been on hospice care for quite a while now, but still hanging in there. Funny enough, the first decent money I made in this industry I was literally in her hospital room after her first real health incident, trading Canopy on my laptop. But she's the one who found that scholarship that really provided me with tons of opportunities and experiences, so she deserves whatever care I can give her now. Researching the cannabis industry is also legitimately just super interesting to me, so it's basically a fun hobby that I can do while I spend a bunch of time at home, that has also made me money.

GeoLogic23

This Texas news isn't even affecting low dose beverages, right? It's just Delta 8 and THCa. Delta 8 isn't used by the hemp beverage companies, and including total THCa in calculations also wouldn't affect beverage products, which are made with just Delta 9 THC.

GeoLogic23

I think it's just more affirmation that synthetic products are never going to be on the market. HHC being clarified as Schedule 1 would be something that hemp beverage companies want, because they are advocating for only naturally extracted Delta 9 to be used in products. Getting rid of synthetic products is desirable for the good-faith actors in both markets. Honestly I don't pay a ton of attention to what the House does. Just like it didn't matter that they passed SAFE a bunch of times. The Senate is what really matters. Not only that, but even if somehow the ban was completed in its current form, there are already state-regulated hemp markets. No real reason to think those markets couldn't continue, just like state-regulated cannabis markets have operated for many years. Listening to prominent players in the hemp beverage market, none of them seem to actually be worried that the entire sector is just going to disappear. And then isn't the most recent Texas news two separate rulings? One that synthetic THC is banned (Delta 8), while the other that natural THC is still allowed (Delta 9 / THCa)? It's hard to keep up with all the court rulings, appeals, injunctions, etc.. [https://www.kut.org/business/2026-05-01/austin-tx-hemp-cannabis-ruling-temporary-injunction-granted-thca](https://www.kut.org/business/2026-05-01/austin-tx-hemp-cannabis-ruling-temporary-injunction-granted-thca) >Judge Daniella DeSeta Lyttle granted a temporary injunction Friday, **stopping Texas health officials from enforcing a new "total delta-9 THC" standard that counted THCA** toward the legal THC limit for consumable hemp products. THCA is a **naturally occuring compound** in cannabis that converts into Delta-9 when heated or smoked. >The judge also blocked certain restrictions on transporting hemp, sharply higher fees charged to businesses and a penalty structure that would have treated each day of some violations as a separate violation. >The ruling came the **same morning as a separate Texas Supreme Court decision involving Delta-8 THC**, which is generally considered to be slightly less psychoactive than Delta-9. >In that case, the high court ruled the state can treat **manufactured Delta-8 products made from hemp-derived CBD as controlled substances**, reversing an injunction that had protected those products from enforcement. Note they do specifically say "manufactured" Delta-8, because technically there is a very very small quantity of naturally occurring Delta 8 in hemp. So both the HHC federal move and the Texas Delta 8 move are about treating synthetic hemp cannabinoid products as controlled substances, instead of federally legal hemp. Imo this is a good thing for both the Delta 9 beverage market, and the regulated cannabis market.

strakerak

Cannabinoid based treatments, listed as Cannabis on RH, they're very much in the THC/CBD spot, just not in the smoking marijuana sense.

AverageNo130

A Texas judge has issued a temporary injunction that continues to prevent state officials from enforcing new [rules restricting access to hemp-derived products such as smokable THCA flower](https://www.marijuanamoment.net/texas-judge-pauses-new-rules-banning-hemp-products-like-smokable-thca-flower-amid-legal-challenge-from-industry/). Meanwhile, the state Supreme Court in a separate case is allowing regulators to ban delta-8 THC. MM

GeoLogic23

I don't know how many times I heard Irwin Simon say something to the effect of "If we could sell THC drinks in the US....". Yes definitely part of their stated reasoning was simply weathering the cannabis market, but they have definitely said for years that if they could sell THC drinks in the US that they thought it would be a gigantic opportunity. If they simply wanted to weather the cannabis market they could have started growing flowers like ACB, or into any other sort of industry. They chose to focus almost completely on the alcohol industry, for the specific reason of the future synergies with cannabis. It's totally reasonable for you to think these assets won't produce anything for years. Others may think the expansion of the hemp beverage market is coming sooner. They definitely need the breweries they bought if the hemp beverage market continues the way it's going though. It's looking more like a craft beer type market so far, since the states aren't operating under uniform sets of rules. So you'd need various breweries in individual states. Like I know RYM has different contract brewers for each state they are in, from looking at their COAs. Regardless, Tilray may not be a winner in any case. But I personally think their strategy is pretty clear for the most part.

heliumbox

"Their whole plan was to buy these assets then consolidate them. Breaking up the assets would be the opposite. People keep acting like they are a cannabis company and a separate alcohol company, when they have been saying for years their primary goal is to sell THC beverage products. " I dont really think this is entirely true. They long said rhey were looking to diversify into "Tilray brands" and buy adjacent industries to weather the storm of shitty weed margins and over saturation in the space. They obviously "can" utilize some of these beverage companies but they really did not need so many shitty "depreciated brands" or distilleries. They also paid a significant premium for many of these assets that will take years and years to realize any benefits.

GeoLogic23

Canada doesn't allow beverages in regular retail. That is the one thing that needs to happen for the Canadian market to completely change. That's what happened in Minnesota that set off the entire US hemp beverage market. Suddenly we have proof in many different states, in many different outlets (beer store, liquor store, convenience stores, pubs, special events, etc..) that these things actually sell really well when you put them in front of the type of consumer that actually drinks them. And yes, the fact they are easier to produce yet demand a higher price are exactly why they are so appealing as an investor. Think of the margin swing by replacing a crappy beer brand with a high margin THC brand. And you don't even need to sell nearly as much volume to make the same revenue either. That's distribution savings. Beverages are heavy. Doesn't Tilray have a very high percentage of the Canadian beverage market? I don't recall the exact number. It's not like they can create a market out of thin air. But when that market expands due to change in retail access, it will be the people with market share and retail connections that will be the eventual winners. And in the US, most beverage brands have no way to scale THC to a national brand. They are just using THC beverages to survive, but they don't have the brewing capacity and consistency to be a part of a major alcohol company's push into THC. Alcohol companies got sued a while back for incorrect ABV % on products. They aren't taking a chance with inconsistent THC production. The national brands will be those with large brewing operations that have experience with creating consistent THC products. And speaking of consistent dosages. Back in 2019 the beverage market was put on a brief hold, because Canopy identified that can liners were causing cannabinoids to stick to them, causing very inconsistent dosages. That got fixed, but then we also had COVID. So there were real reasons that Canopy collapsed when it did. People keep acting like they just threw away their billions. But they had the absolute worst timing possible to have COVID hit them. Probably could have righted the ship faster afterwards, but that's another story.

skyplt29

Thanks Geo. I thought they would have been further down the road on THC beverages, especially in Canada. Funny these are easier to make. I note THC beverages are running at a higher purchase price than alcohol based. It will be interesting to see where hemp falls come Nov. Hopefully the July meetings render that redundant.

GeoLogic23

Idk I assume whatever documentation on this stuff would be found in their SEC filings. No idea how you would actually go about actually valuing a lot of that stuff though. I can't imagine the value is higher than their market cap though. I definitely don't see them in breakup territory. Their whole plan was to buy these assets then consolidate them. Breaking up the assets would be the opposite. People keep acting like they are a cannabis company and a separate alcohol company, when they have been saying for years their primary goal is to sell THC beverage products. Breaking up these assets defeats that plan. They're set to replace underperforming beer brands with new THC brands, utilizing that space on the shelves they already have secured. THC beer has not hit the market yet, but I expect once it does you will quickly see Tilray release a Runners High THC version. Simultaneously they can take advantage of how much easier it is to make THC drinks over beer, and they can also make money as a contract brewer for anybody else looking to scale THC seltzers, mocktails, and other non-beer drinks. Or be the go-to THC beer contract brewer. Idk. But they definitely have options with their current assets. Of course this is all dependent on hemp beverages remaining on their growth trajectory, and not interfered with too much by the federal government.

GeoLogic23

I really don't think this is related, but CWEB just announced they are graduating to the [OTCQX market](https://www.globenewswire.com/news-release/2026/04/30/3284662/0/en/otc-markets-group-welcomes-charlotte-s-web-holdings-inc-to-otcqx.html) from the OTCQB market. This is just days after [WeedMaps delisted to the OTCQX](https://www.globenewswire.com/news-release/2026/04/27/3281458/0/en/otc-markets-group-welcomes-wm-technology-inc-to-otcqx.html). Again absolutely zero real reason to think this is related. Just a curious timing I noticed, as I'm trying to guess what WeedMaps next move is. I still think WeedMaps are going to do something in Florida, with AYR's assets my most recent guess. CWEB does have an active [option to purchase their founder's THC business](https://www.prnewswire.com/news-releases/charlottes-web-positions-to-enter-us-cannabis-wellness-market-301239203.html) though, which I know operates in Florida. >"....provides Charlotte's Web the optionality to acquire Stanley Brothers USA on the earlier of three years from the effective date of the Option and federal legalization of cannabis in the United States, or such earlier time as Stanley Brothers USA and Charlotte's Web may agree (the "Triggering Event") potentially including when otherwise permitted by the policies of the stock exchange on which the Company's securities are listed for trading."

AverageNo130

A[ new study](https://pubmed.ncbi.nlm.nih.gov/42053412/) found that hemp THC products were sold to pseudo-underage buyers without checking ID more than half the time during purchase attempts in Minnesota. By comparison, ID check rates at licensed cannabis stores is over 95%. The study, published in the Journal of Studies on Alcohol and Drugs, was conducted by researchers from the University of California and the University of Minnesota School of Public Health. MH

Forest_City_Frolfer

Had their sales garnished directly by the CRA in the case of THC Biomed. Canadabis had a payment plan in place with the CRA but the CRA is being much more hawkish now. Canadabis was sent a demand letter giving them 14 days to make up the arrears. Unfortunately the CRA isn't going to get their money anyways since the courts will protect the company and the executives. There also won't really be much consolidstion since the company will be purchased by someone who will continue with a clean sheet until they also run out of money.

Forest_City_Frolfer

Canadabis Capital Inc (TSXV:CANB) a Canadian LP out of Alberta, has entered creditor protection after being shaken down by the CRA. They will be undergoing a SISP, soni am interested in who picks them up. They had a deal with Simply Solventless fail not too long ago. Ironically Simply Solventless is also going through creditor protection as well. THC Biomed also went under CCAA but they've been a zombie for a long time.

Metal-Water

Yeah keeping my job it pays decent, but is soul crushing. Looking for a new gig, the tech job market is a little tough right now. I eat really healthy and workout religiously. Need to stop using THC vape pens to escape from my troubles for sure. Trying to stay strong 💪Thanks bro

Metal-Water

Not alcohol, THC concentrates. Yeah I do walk, hit the gym, etc. Just feeling hopeless right now

volckerwasright

Rythm introduced a spirits style THC product (1777 THC Agave Spirit), looks like about 10-15 doses in a bottle. Interesting that they are still adding new form factors/manufacturing lines in light of the regulatory uncertainty.

CornMonkey-Original

now time for the trifecta - gummies, THC vape, & a Celsius, for bath time. . . relax and pretend my positions for tomorrow aren’t regarded.

seung-min-shin

The Schedule 3 reclassification will only benefit U.S.-based MSOs through immediate tax relief. Tilray, which has just been selling beer as a 'THC company,' won't see a single positive metric on their balance sheet. Furthermore, MSOs build shareholder trust by buying back shares, with executives and owners holding significant stakes. But Tilray? They do nothing but dilute shares all day while hiring shills to spread toxic positivity on SNS or Reddit just to dump their stock. I guarantee you, if any positive THC news breaks, Tilray will just issue as many shares as they had before the reverse split, then funnel half of that into Irwin Simon’s pocket and waste the other half on buying some damn beer companies.

Put_Er_There_Sport

While THC influences your metabolism it does not, in the end, choose what you eat. On the flip side as well to argue that it protects your body, THC and other cannabinoids are used amongst cancer patients to allow them to bypass nausea to allow them to eat, keeping them from vomiting stomach acid and saving their esophagus from deteriorating. So no; thc doesnt destroy your stomach. The sugar coated boxed snacks you chose over fresh fruits and veggies is the cause of that. Blaming THC is just lacking accountability.

It-s_Not_Important

THC will damage your stomach from the munchies.

Put_Er_There_Sport

THC at least wont cause you to go into a blind rage over something you dont understand, destroy your liver, kidneys, or stomach, and its damn near impossible to intake so much that you pass away that night. While they cant go without substances, their choices are wildly beneficial for everyone around them regardless of their viewpoints of sobriety

pleasestoptalkin

So many of my friends have quit drinking and now use THC like everyday and call themselves “sober.” Dog, you a drug addict.

Zephod03

"But CBD and THC are two different-" "JuS sHuDdUp AnD tAkE yEr WiN dErP!!"

elh0mbre

Yea, I'd say its protecting the children. Recreational cannabis: Must be 21 to enter the store Hemp THC: Can be bought by a child on the internet Nothing stopping these producers from getting a license and setting up shop legitimately instead of crying about a loophole being closed.

CallShot7029

Yes. And I think that’s the most prominent upside for those who can invest in FDA research and approvals. Can you imagine hospitals giving out THC pills at the volume they used to give out opiates as a direct replacement for same? Then, the money from that being billable to insurance? That’s the real race here.

selesnyaTroll

Alright so I'm up to a bunch of dips that I'm now eyeing up. AMTM, DE, some set of defense/aero names - GD/GE/TXT/NOX, dollar stores maybe DG/DLTR, LLY, and healthcare as well - THC/UHS. Gotta start picking between all these to slowly start adding positions lmao

King_Chron

In 2026, **MariMed Inc. (MRMD)** maintains a dominant medical position, with its flagship brand [**Betty’s Eddies**](https://www.bettyseddies.com/) ranking as a **top 3 edible brand** in **four key states**: [](https://ir.marimedinc.com/news-events/press-releases/detail/296/marimed-reports-fourth-quarter-and-full-year-2025-earnings) [](https://ir.marimedinc.com/news-events/press-releases/detail/296/marimed-reports-fourth-quarter-and-full-year-2025-earnings)[Massachusetts](https://www.google.com/search?q=massachusetts&kgmid=/m/05k7sb&sa=X&ved=2ahUKEwiq74WggoeUAxWkIEQIHQG5DKAQ3egRegYIAQgCEAQ), [Maryland](https://www.google.com/search?q=maryland&kgmid=/m/04rrd&sa=X&ved=2ahUKEwiq74WggoeUAxWkIEQIHQG5DKAQ3egRegYIAQgCEAY), [Delaware](https://www.google.com/search?q=delaware&kgmid=/m/026mj&sa=X&ved=2ahUKEwiq74WggoeUAxWkIEQIHQG5DKAQ3egRegYIAQgCEAg), [Illinois](https://www.google.com/search?q=illinois&kgmid=/m/03v0t&sa=X&ved=2ahUKEwiq74WggoeUAxWkIEQIHQG5DKAQ3egRegYIAQgCEAo) While many competitors focus on high-potency recreational gummies, Betty's Eddies was founded by patients specifically for [therapeutic wellness](https://www.bettyseddies.com/products/ache-away-eddies). Its medical popularity is driven by **targeted formulations** that combine full-spectrum cannabis with specific herbal supplements to treat core ailments:  * **Pain & Inflammation**: **"Ache Away"** chews use a blend of THC, **CBC** (specifically for nerve pain), and **CBD**, supplemented with organic [turmeric and piperine](https://www.gpwellness.com/blog/featured-product-bettys-eddies) for maximum absorption. * **Sleep/Insomnia**: **"Bedtime Betty’s"** feature a ratio of THC, CBD, and CBN, often including melatonin or valerian root to help patients fall and stay asleep. * **Stress & Anxiety**: **"Take It Easy"** chews use [L-theanine and passionflower](https://www.terpenejourney.com/cannabis-brand/bettys-eddies) to provide a "meditative" effect without heavy sedation. * **Energy/Fatigue**: The **Watermelon** formula includes THCV and natural caffeine to aid focus and suppress appetite.  Betty's Eddies +3 **2026 Medical Market Performance** * [**Maryland**](https://www.google.com/search?q=maryland&kgmid=/m/04rrd&sa=X&ved=2ahUKEwiq74WggoeUAxWkIEQIHQG5DKAQ3egRegYIAQgIEAI) : Betty's Eddies was the **#1 overall brand** in late 2025 and held the **#2 spot** through March 2026. It remains a top choice at specialized medical-leaning dispensaries like [Peake ReLeaf](https://peakereleaf.com/best-edibles-maryland/). * **Maine Expansion**: In July 2025, MariMed signed a new agreement with The Stoned Moose specifically to enter the Maine **medical market**, where medical sales previously accounted for over 50% of the state's revenue. * **Awards**: The brand has been named **"Best-Selling Medical Product"** by LeafLink and "Edible of the Year" by *Explore Maryland*.  Headset data +3

Praise-Buddallah

You understand all regular weed is THCa weed until you smoke it right? There's just never been a need prior to the farmbill loops holes to specify it as such. You know since the bill specified ∆9THC

anonymoose_baker

You just need to be carful of additives being added to enhance the potency. THCA is simply dormant THC that hasn’t been combusted into smoke.

slo1111

THC is kind of a back bone compound and it gets altered to different compositions.  THCA adds a carboxyl group to THC.  When it gets heated it loses the carbon group and becomes indistinguishable from THC.  I notice no difference of potency or effect

justify-my-buy-bam

Full legalization is only going to occur when the corporate pirates are bound to profit 1st. First being big pharma Second will happen when alcohol can control the THC infused product market.

paulraymondjohn

“Harmful” is >3mg of THC per the RFK/DrOz’s CMS coverage

RudeGolden

Yeah, like .2%. You're delusional AF if you think this is bullish for THC.

TroubledAcorn

No. He wants congress to update it so people can continue to have access to it. Full Spectrum means CBD that has THC in it.

GeoLogic23

Yea I've been trying to point out that the fentanyl bill was a [bad sign for rec cannabis](https://www.reddit.com/r/weedstocks/comments/1o8xbiy/comment/njy9mw7/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) ever since it passed. Idk why anybody was ever so certain this administration was going to help recreational cannabis after all their rhetoric against it. What I am hoping for is that they are going to regulate hemp beverages. And if they are doing that they are already applying a tax on recreational THC. Seems like an easy way to still "penalize" recreational products compared to medical products if they just use that opportunity to apply a replacement tax to rec products. Then there wouldn't be much harm in allowing rec products to go to Schedule 3, to get rid of legal liability issues. I just don't see them simply allowing both med/rec to go to Schedule 3 and remain on an even playing field. I think if this government is going to help rec cannabis in any way, then there has to be some sort of federal advantage to being a medical only company.

AverageNo130

Republican lawmakers have filed amendments to sweeping agriculture legislation that would push back the scheduled federal recriminalization of hemp THC products for another year and create a framework for continued legal sales, with new restrictions and [clarifications.MM](http://clarifications.MM)

Imaginary_Rooster622

My Bad. I mistook the 6/29/26 hearing as Rescheduling to S3. I now see that the Final Order made medical cannabis from licensed state operators immediately Schedule 3.( Full Stop ) I don't expect the top tier mso's to sit on their hands when Cannabis just became a Schedule 3 substance. Uplisting, Safe banking, M&A Facts First. The DOJ (together with the DEA) issued a Final Order this morning (link here) and also summarized it here, regarding the rescheduling of cannabis. Verbatim, • The FO immediately (4/23) places both FDA-approved products containing marijuana and marijuana products regulated by a state medical marijuana license in Schedule III of the Controlled Substances Act, and it announced the initiation of an expedited administrative hearing process to consider the broader rescheduling of marijuana from Schedule I to Schedule III. • The new hearing, beginning 6/29/26, will provide a timely and legally compliant pathway to evaluate broader changes to marijuana’s status under federal law. DEA is expeditiously moving forward with the administrative hearing process, “bringing consistency and oversight to an area that has lacked both”, according to DEA Administrator Terry Cole. • Cannabis remains federally illegal, and interstate traffic is not allowed. However, the FO also establishes an expedited registration process under 21 CFR part 1301 for entities holding state medical marijuana licenses, enabling such entities to engage in the manufacture, distribution, and/or dispensing of marijuana for medical purposes under federal law consistent with the requirements of the UN Single Convention. • The FO does not apply to synthetically derived THC, which is outside the Visa's definition of Marijuana

ThePermafrost

Yes, in the same way that we have THC medicines that work, but they are not yet FDA approved. The lack of FDA approval doesn’t negate the capabilities of the medicine. It just means it’s not legal yet.

TracyM45

$TLRY Tilray will access US market with prescriptoon THC in 6 months

Butthole--pleasures

This is exciting. Its rescheduling with caveats but I'll take it. After a quick Google search, 40 states + DC have comprehensive medical marijuana programs. The other 10 have low THC or CBD programs. This is essentially rescheduling nationwide. Should clear the way for SAFE methinks. Can't wait for uplisting.

TracyM45

$TLRY Tilray coming across the border in 6 monthd to fill prescriptions for THC